[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350646-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350646-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-serum-5trf-val-as-a-promising-non-invasive-biomarker-for-early-detection-of-esophageal-cancer","Identification of serum 5’tRF-Val as a promising non-invasive biomarker for early detection of esophageal cancer","","Esophageal cancer is often detected at an advanced stage due to the absence of effective noninvasive screening tools, contributing to poor outcomes. This study aimed to identify serum tsRNA biomarkers for early detection of esophageal cancer. Candidate tsRNAs were screened with the tsRFun database, then a qRT-PCR assay for serum 5’tRF-Val was developed and validated. Across 289 participants, 5’tRF-Val was elevated in patients and tracked disease aggressiveness, enabling discrimination of early-stage cases and postoperative monitoring.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-serum-5trf-val-as-a-promising-non-invasive-biomarker-for-early-detection-of-esophageal-cancer/350646/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-serum-5trf-val-as-a-promising-non-invasive-biomarker-for-early-detection-of-esophageal-cancer/350646.png","ImageObject",300,407,{"name":42,"@type":43},"awa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of identifying serum 5’tRF-Val?","Question",{"text":63,"@type":64},"To find and validate serum tsRNA biomarkers that enable noninvasive early detection of esophageal cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the biomarker 5’tRF-Val measured?",{"text":68,"@type":64},"Candidate tsRNAs were screened using the tsRFun database, and serum 5’tRF-Val was quantified using a qRT-PCR method.",{"name":70,"@type":61,"acceptedAnswer":71},"How did 5’tRF-Val perform for early-stage esophageal cancer detection?",{"text":72,"@type":64},"It showed high accuracy for early-stage disease with an AUC of 0.857, and it differentiated early lesions from benign lesions with an AUC of 0.824.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350646,1790838496,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification of serum 5’tRFVal as a promising non-invasive biomarker for early detection of esophageal cancer  \nLiheng Zhang1, Boyu Zi2, Jingyi Hong2, Yibiao Chen1, Shaoqing Ju2, Rongrong Jing2, Ming Cui2􀀍 & Chun Cheng1􀀍  \nEsophageal cancer (EC) is frequently detected at an advanced stage because of the lack of effective noninvasive screening tools, leading to poor prognosis. This study aimed to identify serum transfer RNA-derived small RNA (tsRNA) biomarkers for early detection of EC. Candidate tsRNAs were screened using the tsRFun database, and a quantitative real-time PCR (qRT‒PCR) method for serum 5’tRF-Val was subsequently established and validated. A total of 289 participants were enrolled, including 124 EC patients (71 with early-stage, 53 with advanced-stage disease), 56 individuals with benign lesions, 77 healthy subjects, and 32 postoperative EC patients. Detection performance was evaluated by receiver operating characteristic (ROC) curve analysis, and correlations with clinicopathological parameters were examined. 5’tRF-Val levels were significantly higher in the serum of EC patients than in that of healthy subjects. Its expression correlated positively with aggressive pathological features, including advanced TNM stage and the presence of metastasis. Notably, 5’tRF-Val demonstrated high detection accuracy for early-stage EC, with anAUC of 0.857. Importantly, it effectively distinguished early EC lesions from benign lesions (AUC = 0.824) . Furthermore, longitudinal analysis revealed a significant decrease in 5’tRF-Val levels following radical surgery, suggesting its potential for monitoring treatment response. Serum 5’tRF-Val was identified in this study as a novel and promising noninvasive biomarker for the early detection of EC. Owing to its high detection accuracy, association with disease progression, and postoperative dynamic changes, 5’tRF-Val may help to fill the current gap in noninvasive detection of early EC, but this needs to be further verified in multicentre studies.  \nKeywords Esophageal cancer, Early detection, Serum biomarker, Translational medicine, Liquid biopsy, tsRNA  \nEsophageal cancer (EC) is a major public health problem worldwide. As it is the seventh most frequently diagnosed malignant tumour worldwide, approximately 470,000 new cases are reported per year1, with an overall five-year survival rate of approximately 20%2. This poor prognosis is largely attributable to late detection. EC is typically detected at an advanced stage, often because early symptoms are absent, which limits the feasibility of curative treatment. As a result, even recent surgical and immunotherapeutic advances have resulted in limited improvements in survival3,4. Improving early detection is therefore critical. However, although endoscopic biopsy remains the gold standard for diagnosis, its invasiveness, high cost, and reliance on specialized personnel severely limit its applicability in large-scale screening5, creating an urgent need for novel, noninvasive biomarkers. Currently, pan-cancer analytical strategies capable of integrating multi-omics data to systematically uncover molecular signatures shared across different cancer types have been widely adopted, for instance, have identified broadly dysregulated biomarkers such as CORO1A, CLIC6, BEND3, and PPME16–9 and hold clear value for population-wide screening; however, the design of these signatures favours universal signals over tissue-specific traits and therefore cannot provide specific detection of EC. This inherent lack of specificity substantially also limits their ability to distinguish early-stage malignancies from benign lesions, which is a limitation, especially for EC. In this context, transfer RNA-derived small RNAs (tsRNAs) have recently emerged as a promising alternative class of liquid biopsy biomarkers. Specifically, generated by site-specific tRNA cleavage under cellul","cbCaim8nFus6Tvto","https://ap.wps.com/l/cbCaim8nFus6Tvto","pdf",3331017,13,"English","# Methods\n## Study design, participants, and sample collection","[{\"question\":\"What was the purpose of identifying serum 5’tRF-Val?\",\"answer\":\"To find and validate serum tsRNA biomarkers that enable noninvasive early detection of esophageal cancer.\"},{\"question\":\"How was the biomarker 5’tRF-Val measured?\",\"answer\":\"Candidate tsRNAs were screened using the tsRFun database, and serum 5’tRF-Val was quantified using a qRT-PCR method.\"},{\"question\":\"How did 5’tRF-Val perform for early-stage esophageal cancer detection?\",\"answer\":\"It showed high accuracy for early-stage disease with an AUC of 0.857, and it differentiated early lesions from benign lesions with an AUC of 0.824.\"}]","Identification of serum 5’tRF-Val as a promising non-invasive biomarker for early detection of esophageal cancer | PDF",1790090382,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7d8f31d74b7ce03d0bf2b60d2d4e760.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dfa6532fc87bc25adbde2ac92b84d9a.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7e4378c190800bf507d7995d6b82d4b.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e1df576b6ae5cd73a9e9effe8ec25c8.webp",980,1287]